A Randomized, Open-label, Two-way Crossover Study to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg After a Single Oral Dose in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Tenofovir disoproxil orotate (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 10 Apr 2017 Status changed from recruiting to completed.
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 01 Oct 2015 New trial record